Corrin Wohlhieter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Corrin Wohlhieter has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Charles M. Rudin
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
18 shared publications - Alberto M. Herrera
Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, USA
17 shared publications - Ali Rashidfarrokhi
Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
17 shared publications - Anastasia-Maria Zavitsanou
Department of Pathology, New York University Grossman School of Medicine, New York, New York
17 shared publications - Andre L. Moreira
Department of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
17 shared publications - Anna H. Yeaton
Department of Pathology, New York University Grossman School of Medicine, New York, New York
17 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Elsevier in Translational Oncology
- Vol. 71
SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
- 20 July 2026
- Published by Elsevier in Translational Oncology
- Vol. 71
Open AccessSMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Gating strategy for immune cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Gating strategy for immune cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S2 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune Analysis of Lkb1 mutant lung tumors by scRNA-seq.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S2 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune Analysis of Lkb1 mutant lung tumors by scRNA-seq.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of murine Lkb1 mutant lung tumors by flow cytometry.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of murine Lkb1 mutant lung tumors by flow cytometry.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Loss of function mutations in Lkb1 enhance tumorigenesis.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Loss of function mutations in Lkb1 enhance tumorigenesis.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Depletion of interstitial macrophages in Lkb1 mutant lung tumors after clodronate administration increases effector T cell function.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Depletion of interstitial macrophages in Lkb1 mutant lung tumors after clodronate administration increases effector T cell function.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
LIF neutralization eliminates a dedifferentiated stem-like tumor cell state.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
LIF neutralization eliminates a dedifferentiated stem-like tumor cell state.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Lkb1 mutant tumors transcriptionally upregulate the cytokine LIF.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Lkb1 mutant tumors transcriptionally upregulate the cytokine LIF.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Autocrine LIF signaling enhances tumorigenesis and inflammation.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Autocrine LIF signaling enhances tumorigenesis and inflammation.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S5 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of human LKB1 mutant lung tumors.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S5 from LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer
Immune analysis of human LKB1 mutant lung tumors.